• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Small Cell Lung Cancer

The AJMC® Lung Cancer compendium is a comprehensive resource for clinical news and expert insights for the condition.

Latest News

The new study suggests LTF should be considered as a potential biomarker of first-line treatment response in patients with ES-SCLC. | Image credit: appledesign - stock.adobe.com
Baseline LTF Linked With Treatment Response in SCLC

April 8th 2025

In a small study, lactotransferrin (LTF) was identified as a potentially important biomarker in extensive-stage small cell lung cancer (SCLC).

Doctor showing patient x-ray of lung cancer. | Image credit: Nattakorn – stock.adobe.com
3 DDR Phenotypes May Predict Chemotherapy Response in SCLC

March 25th 2025

In SCLC, transcription factors have also been found to play a key role in chemoresistance, and differences in expression of transcription factors have been tied to drug sensitivities. | Image credit: Rasi-stock.adobe.com
Examination of FOXP1 in SCLC Yields Potential Strategy Against Chemoresistance

March 20th 2025

Lung cancer illustration | Image credit: SciePro - stock.adobe.com
Use of AI Lets Health System Find Lung Cancer at Early Stages

March 8th 2025

lung cancer | Image credit: Crystal light - stock.adobe.com
Study Launches Exploring Peluntamig Combo in DLL3-Expressing Tumors

March 5th 2025

Latest CME Events & Activities
<1
...
678910
© 2025 MJH Life Sciences
AJMC®
All rights reserved.